Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insight Molecular Diagnostics (IMDX) Other financing activities (2020 - 2025)

Historic Other financing activities for Insight Molecular Diagnostics (IMDX) over the last 4 years, with Q1 2025 value amounting to $487000.0.

  • Insight Molecular Diagnostics' Other financing activities changed N/A to $487000.0 in Q1 2025 from the same period last year, while for Sep 2025 it was $1.3 million, marking a year-over-year increase of 14591.08%. This contributed to the annual value of $1.4 million for FY2024, which is 22177.99% up from last year.
  • Per Insight Molecular Diagnostics' latest filing, its Other financing activities stood at $487000.0 for Q1 2025.
  • Insight Molecular Diagnostics' 5-year Other financing activities high stood at $2.7 million for Q1 2021, and its period low was -$1000.0 during Q4 2021.
  • Moreover, its 3-year median value for Other financing activities was $538000.0 (2024), whereas its average is $907200.0.
  • Over the last 5 years, Insight Molecular Diagnostics' Other financing activities had its largest YoY gain of 26750000.0% in 2021, and its largest YoY loss of 26750000.0% in 2021.
  • Insight Molecular Diagnostics' Other financing activities (Quarter) stood at -$1000.0 in 2021, then surged by 83700.0% to $836000.0 in 2024, then tumbled by 41.75% to $487000.0 in 2025.
  • Its last three reported values are $487000.0 in Q1 2025, $836000.0 for Q4 2024, and $538000.0 during Q2 2024.